WAM
VCYT icon

Wakefield Asset Management’s Veracyte VCYT Stock Holding History

Wakefield Asset Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
26,914
+429
+2% +$18K 0.36% 84
2026
Q1 		$853K Buy
26,485
+419
+2% +$15.5K 0.23% 135
2025
Q4 		$1.1M Sell
26,066
-12,898
-33% -$520K 0.3% 106
2025
Q3 		$1.34M Buy
38,964
+79
+0.2% +$2.27K 0.37% 86
2025
Q2 		$1.05M Buy
+38,885
New +$1.13M 0.29% 116

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Wakefield Asset Management's VCYT Position: Q2 2026 in Review

Wakefield Asset Management increased its Veracyte (VCYT) stake by 1.6% in Q2 2026, buying an estimated $18K and bringing the position to 26,914 shares worth $1.58M. The position accounts for 0.36% of the portfolio, ranked #84.

Wakefield Asset Management first reported a position in VCYT in Q2 2025 and has held it in 5 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Wakefield Asset Management held 26,914 shares of Veracyte worth $1.58M as of Q2 2026.
  • Wakefield Asset Management bought 429 Veracyte shares in Q2 2026, an estimated $18K.
  • Veracyte made up 0.36% of Wakefield Asset Management's portfolio in Q2 2026, its #84 holding.
  • Wakefield Asset Management first reported a position in Veracyte in Q2 2025 and has held it in 5 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.